Invariant natural killer T‐cell neutralization is a possible novel therapy for human eosinophilic esophagitis
2014 · Clinical & Translational Immunology · 60 citations
https://doi.org/10.1038/cti.2013.13
Cleveland Clinic(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
5
Papers
228
Citations
5
h-index
4
i10-index
Scott Dynda is an academic researcher from Cleveland Clinic. The author has contributed to research in topics: IL-33, ST2, and ILC Pathways & Eosinophilic Esophagitis & Eosinophilic Disorders and Syndromes. The author has an h-index of 5, co-authored 5 publications.
https://doi.org/10.1038/cti.2013.13
https://doi.org/10.1038/icb.2013.21
Click to start Chat